Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127529362 | 12752936 | 2 | F | 20160822 | 20160905 | 20160916 | 20160916 | EXP | GB-MHRA-EYC 00144579 | GB-CIPLA LTD.-2016GB18065 | CIPLA | 0.00 | Y | 0.00000 | 20160916 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127529362 | 12752936 | 1 | PS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | 50 MG, QD | 50 | MG | U | 77162 | 50 | MG | QD | ||||
| 127529362 | 12752936 | 2 | SS | Zopiclone | ZOPICLONE | 1 | Oral | 3.75 MG, QD, AT NIGHT | 3.75 | MG | U | 0 | 3.75 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127529362 | 12752936 | 1 | Anxiety |
| 127529362 | 12752936 | 2 | Sleep disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127529362 | 12752936 | OT |
| 127529362 | 12752936 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127529362 | 12752936 | Hemianopia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127529362 | 12752936 | 1 | 20160822 | 20160823 | 0 | |
| 127529362 | 12752936 | 2 | 20160822 | 20160823 | 0 |